Efficacy and safety of tralokinumab treatment in adults of different racial subgroups with moderate-to-severe atopic dermatitis in three randomized, placebo-controlled phase 3 trials. J of Skin [Internet]. 2023 Mar. 13 [cited 2026 Apr. 20];7(2):s141. Available from: https://skin.dermsquared.com/skin/article/view/2024